- Open Access
Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents
Journal of Nanobiotechnology volume 17, Article number: 33 (2019)
Correction to: J Nanobiotechnol (2016) 14:6 https://doi.org/10.1186/s12951-016-0157-1
After publication of the original article , the authors found that Fig. 2e (Hsp70-Ch-Lf-ZF in Jurkat cells, 2 h), Fig. 5b (control and HSP70-Lf-ZF) and Fig. 5c (control) contained incorrect images. This does not affect the figure legends, results and conclusions of the article.
The correct versions of Figs. 2 and 5 are included with this correction.
The address of the authors was revised and is given in this Correction.
Chaudhary R, Roy K, Kanwar RK, Walder K, Kanwar JR. Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents. J Nanobiotechnol. 2016;14:6. https://doi.org/10.1186/s12951-016-0157-1.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Chaudhary, R., Roy, K., Kanwar, R.K. et al. Correction to: Engineered atherosclerosis-specific zinc ferrite nanocomplex-based MRI contrast agents. J Nanobiotechnol 17, 33 (2019). https://doi.org/10.1186/s12951-019-0443-9